報價延遲最少15分鐘:2026/10/13 15:03 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.6 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.19/0.16
|
|
企業價值
209.92M
|
| 資產負債 |
|
每股賬面淨值
1.04
|
| 現金流量 |
|
現金流量率
0.03
|
| 損益表 |
|
收益
10.16M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands. |
